A randomized trial of genotype-guided dosing of warfarin. - Wikidata - wikimedia - TriplyDB

A randomized trial of genotype-guided dosing of warfarin.

A randomized trial of genotype-guided dosing of warfarin.

http://www.wikidata.org/entity/Q51140132

about

Global implementation of genomic medicine: We are not alone Personalized medicine and stroke prevention: where are we?Impact of New Genomic Technologies on Understanding Adverse Drug Reactions Economic evaluations of personalized medicine: existing challenges and current developments Cardiovascular pharmacogenomics: current status and future directions Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics Individualized medicine enabled by genomics in Saudi Arabia Pharmacogenetics-based warfarin dosing in children Pharmacogenomics of hypertension and heart disease Use of contemporary genetics in cardiovascular diagnosis Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis Respiratory review of 2014: pulmonary thromboembolism Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine Challenges to integrating pharmacogenetic testing into medication therapy management Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade A Model Based Cost-Effectiveness Analysis of Routine Genotyping for CYP2D6 among Older, Depressed Inpatients Starting Nortriptyline Pharmacotherapy A New Pharmacogenetic Algorithm to Predict the Most Appropriate Dosage of Acenocoumarol for Stable Anticoagulation in a Mixed Spanish Population Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations: implications for clinical implementation of pharmacogenomics Integrating dynamic mixed-effect modelling and penalized regression to explore genetic association with pharmacokinetics Progress towards the integration of pharmacogenomics in practice Future translational applications from the contemporary genomics era: a scientific statement from the American Heart Association APOE ε variants increase risk of warfarin-related intracerebral hemorrhage.Use of genetic data to guide therapy in arterial disease.Analyzing the potential for incorrect haplotype calls with different pharmacogenomic assays in different populations: a simulation based on 1000 Genomes data.New pieces to an old puzzle: identifying the warfarin-binding site that prevents clotting.STRATEGIES FOR EQUITABLE PHARMACOGENOMIC-GUIDED WARFARIN DOSING AMONG EUROPEAN AND AFRICAN AMERICAN INDIVIDUALS IN A CLINICAL POPULATION An integrated approach to defining genetic and environmental determinants for major clinical outcomes involving vitamin D.Gastrointestinal hemorrhage in warfarin anticoagulated patients: incidence, risk factor, management, and outcome Pharmacogenomics: Current State-of-the-Art Edoxaban: an update on the new oral direct factor Xa inhibitor.Warfarin pharmacogenetic trials: is there a future for pharmacogenetic-guided dosing?Pharmacogenetics of heart failure.Determinants of the over-anticoagulation response during warfarin initiation therapy in Asian patients based on population pharmacokinetic-pharmacodynamic analyses Implementation and utilization of genetic testing in personalized medicine.Drug-gene interactions: inherent variability in drug maintenance dose requirements Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans.Educating orally anticoagulated patients in drug safety: a cluster-randomized study in general practice Pharmacogenetics of warfarin in a paediatric population: time in therapeutic range, initial and stable dosing and adverse effects.2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.

P2860

Q24658586-95686FE5-9BD4-48BC-A040-6C2042B14117 Q26776296-D1AF8F38-F490-482B-B073-03272C8D994D Q26787099-04EB86C9-EF8C-426F-A533-4C94A85C9EF2 Q26797183-184CBC19-BEAC-49A4-A484-AD4EF4C210DB Q26801183-FD06BCF2-2548-48B5-B6EF-C8FCCFD6BBAC Q26822796-3CBAC78C-AF17-4B79-8F63-05D60AC82D8A Q26861059-7400013F-D2E1-4D03-A370-56FC46B50750 Q27008320-AEC551E5-4568-4CAA-8845-81B2B194A6F8 Q27015722-1E26C8E8-4248-464C-8EED-E9AAC5BC3FC8 Q27025306-7C1BF98D-2DEB-4B49-91A7-273A26831388 Q27026134-6A7DBA02-F2A8-4489-82B0-9E0E072CDD26 Q27028131-FFDC0ADD-DA18-4C42-860F-51AF90FF0ABA Q28066527-D943D67A-7748-4FEF-B3D1-1EE9388B9FCC Q28071448-BC7E924A-F722-4857-8AC7-4A64BB3021BE Q28082835-9432B5E6-7A58-4D9F-B088-DAA7D025F9C4 Q28392069-997E1905-18D3-4A8E-A554-6CD68397AE9B Q28468503-C478BB21-D239-4255-B0BB-7C0CD8CD199D Q28550740-8D8DB078-1562-4ED6-8FCE-DF00AC050996 Q28601852-2693862D-4570-4D3E-A016-E7B5F64B0CDE Q28650281-5041F4C4-CD9B-4E17-BB16-255A14D8B575 Q28652270-6F2EB3CF-B0D5-45F8-858B-1D3D111ABEE9 Q30359686-F7F04F0C-2CC6-4998-948E-DA9B42FB99E5 Q30370833-BF4B0413-7DF3-4D68-92AA-6E4835BBE57E Q30978916-E6840C01-CD21-49B1-90F1-883A823AAD14 Q30999121-C2EB44E4-0718-478E-B798-FF3366F3A90D Q33364524-5C3342D6-3A0A-4A69-B66A-4E837FABD972 Q33557032-3252414C-99E4-485D-8322-8E6416720436 Q33651712-0CDB295B-86BC-446E-B282-99DD9942C99F Q33760056-C486B87A-1D10-4209-9AD2-FBB5FDF7E0F7 Q33891714-3DC2FCEB-9E2C-4961-94E3-81D09AF749F1 Q33935409-A20A47F1-C3A2-45DE-A1AC-E7DDF914417A Q33946309-6B52BBB0-F7F6-4864-BF42-8FE137E4ED57 Q33986293-B6F7912C-BA80-4C5B-8650-F113E671891D Q34078825-DAAB553B-3D59-4FE5-BDC0-961F426EBE09 Q34147916-E0656134-587C-452C-9C46-A5909BAF0D54 Q34154939-8B0A7505-9F14-4735-9C45-FAFC8058CAEA Q34284362-A66B9FA8-B2C1-49DA-9EC5-D1108477DEBB Q34295187-1E247F6D-B18A-4B59-80C4-D014E9B874EE Q34402967-BD509C75-4170-40DC-A9CF-DE763A6AEFE0 Q34436061-00FACE20-17F1-48F9-BCD4-CDB0F7B7C0EB

P2860

A randomized trial of genotype-guided dosing of warfarin.

http://www.wikidata.org/entity/Q51140132

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

A randomized trial of genotype-guided dosing of warfarin.

@en

A randomized trial of genotype-guided dosing of warfarin.

@nl

type

label

A randomized trial of genotype-guided dosing of warfarin.

@en

A randomized trial of genotype-guided dosing of warfarin.

@nl

prefLabel

A randomized trial of genotype-guided dosing of warfarin.

@en

A randomized trial of genotype-guided dosing of warfarin.

@nl

P1433

Q51140132-743EA836-0728-4380-A2F7-67F9CCA0ECD6

P1476

Q51140132-1C8A3A4C-EEC4-4FC1-89D1-D6280B81C3E2

P2093

Q51140132-089C5E82-5974-47FC-8E83-7FE2CF202CE3

Q51140132-13DB10A0-DF30-45BA-9E36-61EB74817EB9

Q51140132-190BE3CD-E602-4D80-860A-C670CC4B7477

Q51140132-1CE60E43-8F2E-4412-8965-2692ADECEFAB

Q51140132-3257DF1A-6748-42A2-BDA3-6B47D54ACB61

Q51140132-36158F02-C7E1-4D52-B38F-B3EED19AFAAC

Q51140132-39C6108F-6511-4488-B760-955D89DAEC56

Q51140132-3EFBE081-64C2-478A-A2F5-ED5D2F565BDF

Q51140132-4E0CAF14-A4F1-4247-8007-3AB0BC7F4ECB

Q51140132-5A56848A-8169-4C57-8A7D-BA094CEF0AB3

P304

Q51140132-4C9463C2-1D9C-4E39-B354-0D258ED77AF9

P31

Q51140132-11FBA6C3-19D5-424D-8ABD-65B34D366434

P356

Q51140132-BEE7E0CC-2176-4158-AE8A-D53AB1538B52

P407

Q51140132-4705FD85-8F12-4E2F-94AC-1940644E2F08

P433

Q51140132-1721F991-6160-4DD8-9243-4720FADBCEE7

P478

Q51140132-B7E8AE28-A4B2-4446-85CB-462EA61F1382

P50

Q51140132-0A8C9135-4968-458D-B012-AB4AF347CBEA

Q51140132-53EBBCD5-3682-49B6-913B-04D5AD90ECD8

Q51140132-66F2990D-1795-48C2-969C-2AB7D2333EBC

Q51140132-75A7345E-54C8-4D5C-BDB3-3A34EEB65F24

P577

Q51140132-89F38DFD-0E3E-41A4-A112-E856602A70F2

P5875

Q51140132-D4AF998B-2ECA-43FF-AF4D-3CD736F67CD1

P698

Q51140132-719B2801-2027-4472-83D9-4369B2D6220B

P356

P1433

The New England Journal of Medicine

P1476

A randomized trial of genotype-guided dosing of warfarin.

@en

P2093

Andrea L Jorgensen

http://www.w3.org/2001/XMLSchema#string

Anke H Maitland-van der Zee

http://www.w3.org/2001/XMLSchema#string

Bengt Wahlström

http://www.w3.org/2001/XMLSchema#string

Cheng Hock Toh

http://www.w3.org/2001/XMLSchema#string

Christina Christersson

http://www.w3.org/2001/XMLSchema#string

Christina Stafberg

http://www.w3.org/2001/XMLSchema#string

EU-PACT Group

http://www.w3.org/2001/XMLSchema#string

Farhad Kamali

http://www.w3.org/2001/XMLSchema#string

Girvan Burnside

http://www.w3.org/2001/XMLSchema#string

Hugo Kohnke

http://www.w3.org/2001/XMLSchema#string

P304

2294-2303

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1311386

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

369

http://www.w3.org/2001/XMLSchema#string

P50

Munir Pirmohamed

Paula Williamson

P577

2013-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261057504

http://www.w3.org/2001/XMLSchema#string

P698

24251363

http://www.w3.org/2001/XMLSchema#string